Skip to main content
SpringerLink
Log in

Intra-ophthalmic Artery Chemotherapy for Retinoblastoma

  • Chapter
  • First Online:
Clinical Ophthalmic Oncology

  • 1051 Accesses

Abstract

The origin of intra-ophthalmic artery chemotherapy (SSIOAC) dates back to the 1950s. Cases of advanced intraocular retinoblastoma with (1) large multiple lesions still having enough normal retina so visual preservation was possible, (2) vitreous seeds, or (3) tumors refractory to other treatments presented a challenge for Reese and other early pioneers in the treatment of retinoblastoma, as they unfortunately still do today (Chap. 9).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Reese AB, Hyman GA, Tapley ND, Forrest AW. The treatment of retinoblastoma by x-ray and triethylene melamine. AMA Arch Ophthalmol. 1958;60:897–906.

    Article  PubMed  CAS  Google Scholar 

  2. Kupfer C. Retinoblastoma treated with intravenous nitrogen mustard. Am J Ophthalmol. 1953;36:1721–3.

    Article  PubMed  CAS  Google Scholar 

  3. Retinoblastoma. In: Reese AB, editor. Tumors of the eye. 2nd ed. New York: Harper and Row; p. 84–161.

    Google Scholar 

  4. Kaneko A, Takayama J, Matsuoka H, et al. Chemotherapy was successful in two cases of recurrence of intraocular retinoblastoma after irradiation [in Japanese]. Rinsho Ganka. 1990;44:289–92.

    Google Scholar 

  5. Mohri M. The technique of selective ophthalmic arterial infusion for conservative treatment of recurrent retinoblastoma [in Japanese]. Keio Igaku (J Keio Med Soc). 1993;70:679–87.

    Google Scholar 

  6. Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion for patients with intraocular retinoblastoma. Int J Clin Oncol. 2004;9:69–73.

    Article  PubMed  Google Scholar 

  7. Inomata M, Kaneko A. Chemosensitivity profiles of primary and cultured human retinoblastoma cells in a human tumor clonogenic assay. Jpn J Cancer Res. 1987;78:858–68.

    PubMed  CAS  Google Scholar 

  8. Suzuki S, Yamane T, Mohri M, Kaneko A. Selective ophthalmic artery injection therapy for intraocular retinoblastoma: the long-term prognosis. Ophthalmology. 2011;118:2081–7.

    Article  PubMed  Google Scholar 

  9. Abramson DH, Dunkel IJ, Brodie SE, et al. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008;115:1398–404. 1404.e1.

    Article  PubMed  Google Scholar 

  10. Gobin YP, Dunkel IJ, Marr BP, et al. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol. 2011;129(6):732–7.

    Article  PubMed  Google Scholar 

  11. Marr BP, Brodie SE, Dunkel IJ, et al. Three-drug intra-arterial chemotherapy using simultaneous carboplatin, topotecan and melphalan for intraocular retinoblastoma: preliminary results. Br J Ophthalmol. 2012;96:1300–3.

    Article  PubMed  Google Scholar 

  12. Shields CL, Bianciotto CG, Jabbour P, et al. Intra-arterial chemotherapy for retinoblastoma report no. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. Arch Ophthalmol. 2011;129(11):1399–406.

    Article  PubMed  Google Scholar 

  13. Muen WJ, Kingston JE, Robertson F, et al. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma. Ophthalmology. 2012;119(3):611–6.

    Article  PubMed  Google Scholar 

  14. Venturi C, Bracco S, Cerase A, et al. Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments. Acta Ophthalmol. 2013;91(4):335–42.

    Article  PubMed  CAS  Google Scholar 

  15. Bracco S, Leonini S, de Francesco S, et al. Intra-arterial chemotherapy with melphalan for intraocular retinoblastoma. Br J Ophthalmol. 2013;97(9):1219–21.

    Article  PubMed  Google Scholar 

  16. Thampi S, Hetts S, Cooke D, et al. Superselective intra-arterial melphalan therapy for newly diagnosed and refractory retinoblastoma: results from a single institution. Clin Ophthalmol. 2013;7:981–9.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Brodie SE, Gobin YP, Dunkel IJ, et al. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma. Doc Ophthalmol. 2009;119:13–22.

    Article  PubMed  Google Scholar 

  18. Tsimpida M, Thompson DA, Liasis A, et al. Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision. Br J Ophthalmol. 2013;97:1464–70.

    Article  PubMed  Google Scholar 

  19. Munier FL, Beck-Popovic M, Balmer A, et al. Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after ophthalmic artery chemotherapy for advanced intraocular retinoblastoma. Retina. 2011;31(3):566–73.

    Article  PubMed  CAS  Google Scholar 

  20. Shields CL, Shields JA. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr Opin Ophthalmol. 2010;21(3):203–12.

    Article  PubMed  Google Scholar 

  21. Vajzovic LM, Murray TG, Aziz-Sultan MA. Supraselective intra-arterial chemotherapy: evaluation of treatment related complications in advanced retinoblastoma. Clin Ophthalmol. 2011;5:171–6.

    PubMed  CAS  PubMed Central  Google Scholar 

  22. Shields CL, Bianciotto CG, Jabbour P, et al. Intra-arterial chemotherapy for retinoblastoma: report no. 2, treatment complications. Arch Ophthalmol. 2011;129(11):1407–15.

    Article  PubMed  CAS  Google Scholar 

  23. Fallaha N, Dubois J, Carret AS, et al. Real-time ophthalmoscopic findings of intraophthalmic artery chemotherapy in retinoblastoma. Arch Ophthalmol. 2012;130:1075–7.

    Article  PubMed  Google Scholar 

  24. Eagle RC, Shields CL, Bianciotto C, et al. Histopathologic observations after intra-arterial chemotherapy for retinoblastoma. Arch Ophthalmol. 2011;129(11):1416–21.

    Article  PubMed  Google Scholar 

  25. Vajzovic LM, Murray TG, Aziz-Sultan MA, et al. Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma. Arch Ophthalmol. 2010;128(12):1619–23.

    Article  PubMed  Google Scholar 

  26. Graeber CP, Gobin YP, Marr BP, et al. Histopathologic findings of eyes enucleated after treatment with chemosurgery for retinoblastoma. Open Ophthalmol J. 2011;5:1–5.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Kim J, Do H, Egbert P. Enucleated eyes after failed intra-arterial infusion of chemotherapy for unilateral retinoblastoma: histopathologic evaluation of vitreous seeding. Clin Ophthalmol. 2011;5:1655–8.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Samuels BL, Bitran JD. High-dose intravenous melphalan: a review. J Clin Oncol. 1995;13:1786–99.

    PubMed  CAS  Google Scholar 

  29. Wilson MW, Haik BG, Dyer MA. Superselective intraophthalmic artery chemotherapy what we do not know. Arch Ophthalmol. 2011;129(11):1490–1.

    Article  PubMed  Google Scholar 

  30. Wilson MW, Jackson JS, Phillips BX, et al. Real-time ophthalmoscopic findings of superselective intraophthalmic artery chemotherapy in a nonhuman primate model. Arch Ophthalmol. 2011;129(11):1458–65.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  31. Tse BC, Steinle JJ, Johnson D, et al. Superselective intraophthalmic artery chemotherapy in a nonhuman primate model. JAMA Ophthalmol. 2013;131(7):903–11.

    Article  PubMed  Google Scholar 

  32. Wilson MW, Qaddoumi I, Billups C, et al. A clinic-pathological correlation of 67 eyes primarily enucleated for advanced intraocular retinoblastoma. Br J Ophthalmol. 2011;95(4):553–8.

    Article  PubMed  Google Scholar 

  33. Jabbour P, Chalouhi N, Tjoumakaris S. Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma: a review. J Neurosurg Pediatr. 2012;10:127–81.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN, USA

    Brian C. Tse MD & Matthew W. Wilson MD

  2. Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN, USA

    Rachel C. Brennan MD

Authors
  1. Brian C. Tse MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rachel C. Brennan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matthew W. Wilson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew W. Wilson MD .

Editor information

Editors and Affiliations

  1. Dept. of Ophthalmic Oncology, Cole Eye Institute Cleveland Clinic Foundation, Cleveland, Ohio, USA

    Arun D. Singh

  2. Department of Ophthalmology, Children's Hospital Los Angeles, Los Angeles, USA

    A. Linn Murphree

  3. University of California, San Francisco, California, USA

    Bertil E. Damato

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Tse, B.C., Brennan, R.C., Wilson, M.W. (2015). Intra-ophthalmic Artery Chemotherapy for Retinoblastoma. In: Singh, A., Murphree, A., Damato, B. (eds) Clinical Ophthalmic Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43451-2_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-43451-2_12

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-43450-5

  • Online ISBN: 978-3-662-43451-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation